BioStock: PHI accelerates growth with record order

Phase Holographic Imaging recently received its most significant order from Altium, comprising 20 HoloMonitor systems and additional components. This milestone aligns with the positive growth trajectory since the start of the year. PHI is also approaching the final exercise day of their TO 4 warrants on October 3, raising up to SEK 6.2 million before issue costs. BioStock reached out to CEO Patrik Eschricht for a comment.

Read the full interview with Patrik Eschricht on biostock.se.

We are thrilled to continue building our partnership with Altium. Their expertise in distribution and life science is key to expanding our market reach.
This latest order exemplifies the momentum we’re seeing, driven by the growing demand for non-invasive cell imaging solutions.